Related Experiment Video
Updated: Jun 9, 2026
09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Copy number variation in Parkinson's disease
1Department of Neurology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien, 0027 Oslo, Norway. mathias.toft@gmail.com.
Genome Medicine
|September 11, 2010
Summary
Copy number variants (CNVs) are key to understanding inherited diseases like Parkinson's. Research on CNVs offers new insights into disease mechanisms and potential treatments.
Area of Science:
- Human genetics
- Neurodegenerative disorders
- Genomic variation
Background:
- Genomic variation is crucial for understanding inherited diseases.
- Copy number variants (CNVs) play a significant role in phenotypic expression.
- Parkinson's disease is a progressive neurodegenerative disorder with limited treatment options.
Purpose of the Study:
- To review the role of copy number variants in Parkinson's disease pathogenesis.
- To explore mechanistic insights provided by CNVs in Parkinson's disease.
- To highlight the importance of genomic variation in disease research.
Main Methods:
- Literature review of studies on copy number variants and Parkinson's disease.
- Analysis of research on monogenic forms of Parkinson's disease.
- Examination of in vivo model systems and novel intervention strategies.
Main Results:
- CNVs contribute to the understanding of Parkinson's disease mechanisms.
- Research on monogenic forms, including those with CNVs, has advanced in vivo models.
- CNVs offer mechanistic insights into Parkinson's disease pathogenesis.
Conclusions:
- Copy number variants are integral to understanding Parkinson's disease.
- Genomic variation research is essential for developing effective Parkinson's disease treatments.
- CNVs provide valuable mechanistic insights into neurodegenerative disease processes.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...